The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality
Woolling KR, Ruston JG. Serum neuritis: report of two cases and brief review of the syndrome. Archives of Neurology and Psychiatry 1950;64:568-573.
World Health Organization. Measles Vaccines, Technical Report No. 263. World Health Organization: Geneva; 1963.
WRC-TV. DPT: Vaccine Roulette. Washington DC: WRC-TV, 1982.
Wright PF, Hatch MH, Kasselberg AG, Lowry SP, Wadlington WB, Karzon DT. Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. Journal of Pediatrics 1977;91:408-412.
Wright PF, Kim-Farley RJ, de Quadros CA, Robertson SE, Scott RM, Ward NA et al. Strategies for the global eradication of poliomyelitis by the year 2000. New England Journal of Medicine 1991;325:1774-1779.
Wutzler P, Sprossig M, Schneider J et al. [A complication after oral protective immunization against poliomyelitis] Komplikation nach oraler Poliomyelitis-Schutzimpfung. Padiatrie und Grenzgebiete 1984;23:289-297.
Wyatt G. Planning an immunization schedule. Practitioner 1992;236:479-480, 482.
Wyatt HV. Poliomyelitis in hypogammaglobulinemics. Journal of Infectious Diseases 1973;128:802-806.
Wyatt HV. Provocation poliomyelitis: neglected clinical observations from 1914 to 1950. Bulletin of the History of Medicine 1981;55:543-557.
Wyatt HV. Did thalidomide promote poliomyelitis following oral poliovirus vaccination in West Berlin in 1960? Perspectives in Biology and Medicine 1983;27:93-106.
Wyatt HV. Injections cripple, injections kill (letter). Journal of the Indian Medical Association 1986;84:193-194.
Wyatt HV. Injections and poliomyelitis: what are the risks of vaccine associated paralysis? Developments in Biological Standardization 1986;65:123-128.
Wyatt HV. Poliovaccination in the Gambia (letter). Lancet 1987;2:43.
Wyatt HV. Incubation of poliomyelitis as calculated from the time of entry into the central nervous system via the peripheral nerve pathways. Reviews of Infectious Diseases 1990;12:547-556.
Xu ZY, Margolis HS. Determinants of hepatitis B vaccine efficacy and implications for vaccination strategies. Viral Hepatitis in China: Problems and Control Strategies. Monographs in Virology 1992;19:87-98.
Yamada A, Takeuchi K, Tanabayashi K, Hishiyama M, Takahashi Y, Sugiura A. Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene. Vaccine 1990;8:553-557.
Yamauchi T, Wilson C, St. Geme JW. Transmission of live, attenuated mumps virus to the human placenta. New England Journal of Medicine 1974;290:710-712.
Yanagi Y, Cubitt BA, Oldstone MB A. Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virology 1992;187:280-289.
Yap I, Guan R, Chan SH. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein—a preliminary study on immunogenicity. Vaccine 1992;10:439-442.
Yeoh EK, Chang WK, Ip P, Chan KH, Chan E, Fung C. Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers. Journal of Infection 1986;13(Suppl. A):15-18.
Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses. Pediatrics 1990;85(4 Pt 2):690-693.